chr11-13694635-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032228.6(FAR1):c.-7-124G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0383 in 770,318 control chromosomes in the GnomAD database, including 719 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.032 ( 113 hom., cov: 32)
Exomes 𝑓: 0.040 ( 606 hom. )
Consequence
FAR1
NM_032228.6 intron
NM_032228.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.382
Genes affected
FAR1 (HGNC:26222): (fatty acyl-CoA reductase 1) The protein encoded by this gene is required for the reduction of fatty acids to fatty alcohols, a process that is required for the synthesis of monoesters and ether lipids. NADPH is required as a cofactor in this reaction, and 16-18 carbon saturated and unsaturated fatty acids are the preferred substrate. This is a peroxisomal membrane protein, and studies suggest that the N-terminus contains a large catalytic domain located on the outside of the peroxisome, while the C-terminus is exposed to the matrix of the peroxisome. Studies indicate that the regulation of this protein is dependent on plasmalogen levels. Mutations in this gene have been associated with individuals affected by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity (PMID: 25439727). A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 11-13694635-G-A is Benign according to our data. Variant chr11-13694635-G-A is described in ClinVar as [Benign]. Clinvar id is 1237394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0322 (4895/152240) while in subpopulation NFE AF= 0.0469 (3190/67980). AF 95% confidence interval is 0.0456. There are 113 homozygotes in gnomad4. There are 2387 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 113 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAR1 | NM_032228.6 | c.-7-124G>A | intron_variant | ENST00000354817.8 | NP_115604.1 | |||
FAR1 | XM_011520400.3 | c.-7-124G>A | intron_variant | XP_011518702.1 | ||||
FAR1 | XM_047427690.1 | c.-7-124G>A | intron_variant | XP_047283646.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAR1 | ENST00000354817.8 | c.-7-124G>A | intron_variant | 1 | NM_032228.6 | ENSP00000346874 | P1 | |||
FAR1 | ENST00000532701.1 | c.-7-124G>A | intron_variant | 2 | ENSP00000437111 |
Frequencies
GnomAD3 genomes AF: 0.0322 AC: 4896AN: 152122Hom.: 113 Cov.: 32
GnomAD3 genomes
AF:
AC:
4896
AN:
152122
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0398 AC: 24590AN: 618078Hom.: 606 AF XY: 0.0386 AC XY: 12271AN XY: 318076
GnomAD4 exome
AF:
AC:
24590
AN:
618078
Hom.:
AF XY:
AC XY:
12271
AN XY:
318076
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0322 AC: 4895AN: 152240Hom.: 113 Cov.: 32 AF XY: 0.0321 AC XY: 2387AN XY: 74430
GnomAD4 genome
AF:
AC:
4895
AN:
152240
Hom.:
Cov.:
32
AF XY:
AC XY:
2387
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
22
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 11, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at